Puerto Rico’s Molecular Sciences Research Center Signals Resurgent Industry

The five-year old center is to include the island’s first preclinical facility. Researchers there are working on an HIV vaccine with support from Amgen, Lilly and the US National Institutes of Health.

More from R&D

More from Scrip